Event Detail

Please join us in the casual setting of the Tokyo American Club to hear

about possibly game-changing medical technologies: Regenerative medicine

may cure or alleviate currently intractable conditions and become a

growing market in the future. Human induced pluripotent stem cells and

embryonic stem cells are attractive source materials with great

potential for regenerative medicine; however, there are many issues to

resolve before their promise can be achieved. Come hear Dr. Kazuhiro

Sakurada, one of the global leaders in stem cell research, discuss

exciting stem cell technologies and the potential and challenges for

using stem cells in regenerative medicine.



Dr. Sakurada is senior researcher and chief distinguished researcher of

Sony Computer Science Laboratories, Inc., where he has worked since

September 2008. Previously he served for 8 months as Chief Scientific

Officer of U.S. based start-up iZumi Bio. Before that, he was Head of

Research Center Japan, Head of Therapeutic Research Group for

Regenerative Medicine and member of the Global Research Management Team

for Bayer Schering Pharma (now Bayer Healthcare Pharmaceuticals), as

well as a member of the Executive Committee of Bayer Yakuhin until

December 2007. Prior to the merger of Bayer AG and Schering AG in June

2006, he was a member of the Executive Board of Nihon Schering and a

member of the Corporate Research Management Team of Schering AG. From

1988 until September 2004, he was employed by Kyowa Hakko where he held

positions of responsibility in Regenerative Medicine and stem cell based

drug discovery. Dr. Sakurada's PhD is from Osaka University. Over his

career, he has had many stem cell related research publications and

patents.



NOTE: This meeting is OFF THE RECORD